User menu

Moclobemide (ro-11-1163) Vs Clomipramine in the Treatment of Depression - a Double-blind Multicenter Study in Belgium

Bibliographic reference Cattiez, PH. ; Dierick, M. ; Troisfontaines, B. ; Vanaudenrode, L. ; Defleur, J. ; et. al. Moclobemide (ro-11-1163) Vs Clomipramine in the Treatment of Depression - a Double-blind Multicenter Study in Belgium. In: Drug Development Research, Vol. 21, no. 4, p. 325-331 (1990)
Permanent URL http://hdl.handle.net/2078.1/51329
  1. Blackwell, Drugs, 21, 201 (1981)
  2. Br. Med. J., 1, 881 (1965)
  3. Crane, Psychiatry Res. Rep., 8, 142 (1957)
  4. and : Ro 11-1163, a specific and short-acting MAO inhibitor with antidepressant properties. In and (eds): ?Monoamine Oxidase. Basic and Clinical Frontiers.? Amsterdam: Excerpta Medica, 1982, pp. 183-196.
  5. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression, 10.1176/ajp.135.4.467
  6. and (eds.): ?Monoamine Oxidase and Disease: Prospects for Therapy with Reversible Inhibitors.? New York: Academic Press, 1984, pp. 429-441.
  7. and : Reversible monoamine oxidase inhibitors and the cheese effect. In and (eds.): ?Monoamine Oxidase and Disease: Prospects for Therapy with Reversible Inhibitors.? New York: Academic Press, 1984, pp. 479-486.
  8. and : Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine. In and (eds.): ?The Cheese-Effect and New Reversible MAO-A Inhibitors.? J. Neural Transmission [Suppl.] 26: 97-104, 1988.
  9. Hollister, Drugs, 22, 129 (1981)
  10. Horwitz David, Lovenberg Walter, Engelman Karl, Sjoerdsma Albert, Monoamine Oxidase Inhibitors, Tyramine, and Cheese, 10.1001/jama.1964.03060390010002
  11. Keller, Naunyn Schmiedebergs Arch. Pharmacol., 335, 12 (1987)
  12. and : ?Daignosis and Drug Treatment of Psychiatric Disorders.? Baltimore: William and Wilkins, 1969.
  13. Kline N. S., Cooper T. B., Monoamine Oxidase Inhibitors as Antidepressants, Psychotropic Agents (1980) ISBN:9783642675409 p.369-397, 10.1007/978-3-642-67538-6_17
  14. and : Tyramine pressor effect in man: Studies with moclobemide, a novel, reversible monoamine oxidase inhibitor. In and (eds.): ?The Cheese-Effect and New Reversible MAO-A Inhibitors.? J. Neural Transmission [Suppl.] 26: 57-71, 1988.
  15. and : Blood pressure response to tyramine-enriched meal before and during MAO-inhibition in man: Influence of dosage regimen. In and (eds.) ?The Cheese-Effect and New Reversible MAO-A Inhibitors.? J. Neural Transmission [Suppl.] 26: 105-114, 1988.
  16. Paykel, Br. J. Psychiatry, 188, 275 (1971)
  17. Quitkin Frederic, Monoamine Oxidase Inhibitors : A Review of Antidepressant Effectiveness, 10.1001/archpsyc.1979.01780070027003
  18. Rabkin, J. Clin. Psychopharmacol., 5, 2 (1985)
  19. and : Clinical psychopharmacology of phenelzine: MAO activity and clinical response. In and (eds.): ?Psychopharmacology: A Generation of Progress.? New York: Raven Press, 1978, pp. 961-973.
  20. Sargant, Br. Med. J., 1, 5 (1962)
  21. West, Br. Med. J., 1, 1491 (1959)
  22. Youdim M. B. H., Finberg J. P. M., Implications of MAO-A and MAO-B Inhibition for Antidepressant Therapy, Monoamine Oxidase and Its Selective Inhibitors ISBN:9783805535953 p.63-74, 10.1159/000407504